Is MediWound Ltd. (MDWD) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 3.0% / 30% | 4.2% / 30% | 2.7% / 30% | 10.13% / 5% | ✗ NOT HALAL |
| DJIM | 3.0% / 33% | 4.2% / 33% | 2.7% / 33% | 10.13% / 5% | ✗ NOT HALAL |
| MSCI | 8.9% / 33% | 12.5% / 33% | 8.0% / 33% | 10.13% / 5% | ✗ NOT HALAL |
| S&P | 3.0% / 33% | 4.2% / 33% | 2.7% / 33% | 10.13% / 5% | ✗ NOT HALAL |
| FTSE | 8.9% / 33% | 12.5% / 33% | 8.0% / 50% | 10.13% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 19.2% | |
| Operating Margin | -417.8% | |
| Net Margin | -140.8% | |
| Return on Equity (ROE) | -63.9% | |
| Return on Assets (ROA) | -19.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$16M |
| Free Cash Flow | -$22M |
| Total Debt | $8M |
| Debt-to-Equity | 20.1 |
| Current Ratio | 2.3 |
| Total Assets | $86M |
Price & Trading
| Last Close | $15.71 |
| 50-Day MA | $17.32 |
| 200-Day MA | $18.18 |
| Avg Volume | 97K |
| Beta | 0.1 |
|
52-Week Range
$14.14
| |
About MediWound Ltd. (MDWD)
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is MediWound Ltd. (MDWD) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), MediWound Ltd. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is MediWound Ltd.'s debt ratio?
MediWound Ltd.'s debt ratio is 3.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 8.9%.
What are MediWound Ltd.'s key financial metrics?
MediWound Ltd. has a market capitalization of $193M, and revenue of $17M. The company maintains a gross margin of 19.2% and a net margin of -140.8%. Return on equity stands at -63.9%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.